April 29, 2024

Office of New Drugs (OND) | Annual Reports

The 2023 OND Annual report captures the office’s achievements, including notable drug approvals, guidances, publications, and staff’s involvement in public meetings, workshops, webinars, and conferences. This […]
April 29, 2024

What’s New in Regulatory Science

Several times a year the Center for Drug Evaluation and Research sends out an update to share information on new developments, opportunities, and initiatives in regulatory […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0